In a transgenic mouse model, monoclonal antibody against ADAM17 potently raised SARS-CoV-2 viral load due to decreased shedding of mACE2 which along with retaining anti-viral defense capabilities through increased Ifnb and Isg56 genes expression, remarkably ameliorated the post-infection inflammatory responses [228]. The gene discussed is ADAM17; the disease is infection.